Reference,Reference: DOI,Assay,Section,Pre-vaccine Infection,Vaccine,# Shots,Months,Host,Control,Control: NT50 Cmp,Control: NT50 GeoMean,Control: NT50 GSD,Variant,Variant: Pos,Variant: Mutations,# Results,Potency: NT50 Cmp,Potency: NT50 GeoMean,Potency: NT50 GSD,Fold Reduction: Cmp,Fold Reduction: Median
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1808.0,1.0,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,583.0,1.0,=,3.1
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1260.0,1.0,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,787.0,1.0,=,1.6
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2651.0,1.0,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,891.0,1.0,=,3.0
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,3242.0,1.0,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,1340.0,1.0,=,2.4
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2270.0,1.0,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,1808.0,1.0,=,1.3
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2610.0,1.0,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,988.0,1.0,=,2.6
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1215.0,1.0,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,515.0,1.0,=,2.4
Choi21,10.1128/JVI.01313-21,Pseudovirus (VSV),Fig 1A,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1046.0,1.0,Iota/E484K,5,L5F + T95I + D253G + E484K + A701V,1,=,343.0,1.0,=,3.0